These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 12406926)
1. Global vaccination meets global terror. CMAJ; 2002 Oct; 167(8):837, 839. PubMed ID: 12406926 [No Abstract] [Full Text] [Related]
2. The costs of scaling up vaccination in the world's poorest countries. Bishai D; McQuestion M; Chaudhry R; Wigton A Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576 [TBL] [Abstract][Full Text] [Related]
3. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective. Peny JM; Gleizes O; Covilard JP Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769 [TBL] [Abstract][Full Text] [Related]
4. Financial challenges of immunization: a look at GAVI. Kaddar M; Lydon P; Levine R Bull World Health Organ; 2004 Sep; 82(9):697-702. PubMed ID: 15628208 [TBL] [Abstract][Full Text] [Related]
5. First countries to be recipients of GAVI funds. Maurice J Bull World Health Organ; 2000; 78(12):1477-8. PubMed ID: 11196504 [No Abstract] [Full Text] [Related]
7. Health costs & financing and the work of WHO. Mach EP World Health Stat Q; 1984; 37(4):339-50. PubMed ID: 6523902 [No Abstract] [Full Text] [Related]
9. Global progress toward universal childhood hepatitis B vaccination, 2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620 [TBL] [Abstract][Full Text] [Related]
10. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications. Goldie SJ; O'Shea M; Diaz M; Kim SY Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626 [TBL] [Abstract][Full Text] [Related]
11. World health and bioterrorism. Vincent J Clin Pharmacol Ther; 2009 Jun; 85(6):561-5. PubMed ID: 19451904 [No Abstract] [Full Text] [Related]
12. Global health. The new world of global health. Cohen J Science; 2006 Jan; 311(5758):162-7. PubMed ID: 16410496 [No Abstract] [Full Text] [Related]
13. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability? Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134 [TBL] [Abstract][Full Text] [Related]
14. GAVI and the Vaccine Fund--a boon for immunization in the developing world. Balaji KA Indian J Public Health; 2004; 48(2):45-8. PubMed ID: 15709583 [TBL] [Abstract][Full Text] [Related]
16. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV? Khan MM Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460 [TBL] [Abstract][Full Text] [Related]
17. The global vaccination gap. Mahmoud A Science; 2004 Jul; 305(5681):147. PubMed ID: 15247440 [No Abstract] [Full Text] [Related]
18. Polio endgame. Polio: The final assault? Roberts L Science; 2004 Mar; 303(5666):1960-8. PubMed ID: 15044779 [No Abstract] [Full Text] [Related]
19. Polio eradication: 7 countries and US$ 210 million to go. Fleck F Bull World Health Organ; 2003; 81(9):696-7. PubMed ID: 14710517 [No Abstract] [Full Text] [Related]